(Tea Party 247) – Amazing.
For so many of the most sinister suspected plots, whenever you follow the money, it seems it goes right back to George Soros.
The biotech firm WuXi AppTech has a facility in Wuhan, China, The Gateway Pundit reports. The company performs well-respected research including in vitro (HTS, SAR screening support) and in vivo disease models in cardiovascular, respiratory, metabolic and infectious diseases.
In August of 2012, this document was filed with the US government:
It reveals that Soros Fund Management LLC invested heavily in WUXI Pharmatech Caymen, Inc.
WuXi App Tech acquired AppTech Laboratory Services in 2008, and was renamed WuXi Apptech since then.
In 2010, before Soros’ heavy investment, WuXi Pharamtech announced plans to build a $100 million R&D center in…Wuhan, China.
Now, as TGP explains they were told by a trusted source, you can’t do virology research and development in any country unless you acquire the necessary contract with the government, such as the DoD or the CDC.
So you can only imagine how strict this is in a country like China. You can’t get viral specimens, have a secure facility, transport specimens, and conduct experiments on live animals without the clearance.
In the case of WuXi AppTech, we can almost guarantee that their work was supervised by Chinese Intelligence considering the company’s close connection to the United States.
Very interestingly, WuXi App Tech provides validated research models on, among other things, in vivo disease models in cardiovascular, respiratory, metabolic, and infectious diseases.
Above image via XRVision Sentinel AI and Yaacov Apelbaum.